home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9603.zip
/
M9630319.TXT
< prev
next >
Wrap
Text File
|
1996-02-27
|
3KB
|
43 lines
Document 0319
DOCN M9630319
TI Prospective cohort study of the effect of pregnancy on the progression
of human immunodeficiency virus infection. The Groupe d'Epidemiologie
Clinique Du SIDA en Aquitaine.
DT 9603
AU Hocke C; Morlat P; Chene G; Dequae L; Dabis F; Service de
Gynecologie-Obstetrique, Hopital Pellegrin, Centre; Hospitalier
Universitaire, Bordeaux, France.
SO Obstet Gynecol. 1995 Dec;86(6):886-91. Unique Identifier : AIDSLINE
MED/96072912
AB OBJECTIVE: To study the prognostic role of pregnancy on the progression
of human immunodeficiency virus (HIV) infection. METHODS: In a
prospective cohort study at the Bordeaux University Hospital, France, 57
women who completed a pregnancy during the course of their HIV infection
were compared with 114 HIV-infected women who never conceived. The two
groups were matched on CD4 lymphocyte count (CD4), age, and year of HIV
diagnosis. The main outcome measures were death, occurrence of a first
AIDS-defining event, and drop of the CD4 below 200/mm3. RESULTS: The
mean follow-up period in pregnant women was 61 months from HIV diagnosis
(median CD4 at entry 455/mm3) and 54 months from beginning of pregnancy.
Nonpregnant women were followed-up for 50 months since HIV diagnosis
(median CD4 460/mm3). The proportion of asymptomatic women at entry in
the study was 51 of 57 (90%) in pregnant and 87 of 114 (76%) in
nonpregnant women. No significant difference was observed between the
two groups with regard to the different end points studied, even after
adjustment for other prognostic variables. Adjusted hazard ratios
(pregnant/nonpregnant) were 0.92 for death (95% confidence interval [CI]
0.40-2.12), 1.02 for occurrence of a first AIDS-defining event (95% CI
0.48-2.18), and 1.20 for drop of the CD4 to less than 200/mm3 (95% CI
0.63-2.27). CONCLUSION: In a cohort of HIV-infected women with mild to
moderate immunosuppression, pregnancy did not accelerate progression to
AIDS or death.
DE Adolescence Adult Comparative Study Confidence Intervals CD4
Lymphocyte Count Disease-Free Survival Female Follow-Up Studies
Human *HIV Seropositivity/IMMUNOLOGY/MORTALITY Pregnancy *Pregnancy
Complications, Infectious/IMMUNOLOGY/MORTALITY Prognosis Prospective
Studies Support, Non-U.S. Gov't Survival Rate JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).